secwatch / observer
8-K filed January 6, 2023, 6:59 PM ET ticker PHGE CIK 0001739174
leadership confidence high sentiment neutral materiality 0.30

Two BiomX board members resign effective immediately

BiomX Inc.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Jonas Grossman

Director
PHGE · BiomX Inc.
Effective
2023-01-05
Filed
January 6, 2023, 6:59 PM ET
On January 5, 2023, Jonas Grossman and Dr. Gbola Amusa each resigned from the Board of Directors (the “Board”) of BiomX Inc. (the “Company”), for personal reasons, effective immediately.
Departed

Dr. Gbola Amusa

Director
PHGE · BiomX Inc.
Effective
2023-01-05
Filed
January 6, 2023, 6:59 PM ET
On January 5, 2023, Jonas Grossman and Dr. Gbola Amusa each resigned from the Board of Directors (the “Board”) of BiomX Inc. (the “Company”), for personal reasons, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Jonas Grossman resigned as Director at BiomX Inc..

Action
resigned
Role
Director
Exact text from the filing
On January 5, 2023, Jonas Grossman and Dr. Gbola Amusa each resigned from the Board of Directors (the “Board”) of BiomX Inc. (the “Company”), for personal reasons, effective immediately.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Dr. Gbola Amusa resigned as Director at BiomX Inc..

Action
resigned
Role
Director
Exact text from the filing
On January 5, 2023, Jonas Grossman and Dr. Gbola Amusa each resigned from the Board of Directors (the “Board”) of BiomX Inc. (the “Company”), for personal reasons, effective immediately.
View on SEC.gov

BiomX Inc. filing history →

Source: SEC EDGAR
accession 0001213900-23-001398
view filing index on sec.gov
view primary document
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.